If the patient is in the stable stage of emphysema, it is recommended to get the New Crown vaccine after talking to the doctor. However, if the patient’s condition is still unstable and symptoms such as coughing, shortness of breath, chest tightness, and breathlessness occur, it is recommended to enter the stabilization phase before receiving the New Crown vaccine. The New Crown vaccine has a very low risk and has a protective effect on the body. If the patient is in the stable stage of emphysema, the clinical symptoms are usually not obvious and medication may not be needed, then the New Crown vaccine can be given. If the patient is in the acute exacerbation phase, there may be respiratory failure and infection due to a significant decline in lung function. In addition, emphysema patients with decreased immunity and lung function during the treatment period may not be able to produce an effective immune response, which may aggravate the condition and cause other side effects. At this time, the injection of the new crown vaccine is likely to aggravate the body’s adverse reactions, so it is recommended that patients inject the new crown vaccine after their condition has stabilized. It is recommended to consult the relevant doctor for details on whether emphysema can be vaccinated with the new coronavirus vaccine.